Ignite Creation Date:
2024-05-06 @ 12:20 PM
Last Modification Date:
2024-10-26 @ 12:57 PM
Study NCT ID:
NCT03739970
Status:
UNKNOWN
Last Update Posted:
2018-11-14
First Post:
2018-10-31
Brief Title:
A Clinical Trial of Silk Peptide for the Evaluation of Efficacy on Immune Function
Sponsor:
Yonsei University
Organization:
Yonsei University
Study Overview
Official Title:
A Clinical Trial of Silk Peptide for the Evaluation of Efficacy on Immune Function Enhancement
Status:
UNKNOWN
Status Verified Date:
2018-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a 8-week randomized double-blind placebo-controlled clinical trial of Silk Peptide for the evaluation of efficacy on immune function enhancement
Detailed Description:
This study will evaluate Silk Peptides efficacy on immune function in healthy volunteers who white blood cells count is in between 4000 and 8000 by assessing improvements in certain immune indices ie NK cell activity IFN-γ TNF-α IL-1β 2 12 IgG1 IgG2
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None